Abbott Hikes Its Dividend Payout 14%

Our success is your success. We've been rewarding investors since 1924.

Strategy and Strength|Dec.15, 2018

Abbott’s impressive financial performance during the past five decades has been differentiating – and we are not letting up.

Recently, we announced we are increasing our quarterly common dividend to 32 cents per share from 28 cents per share. That’s a 14 percent increase in our dividend, which is a result of our work to shape the company to address the most attractive areas of healthcare and build long-term growth potential. And, the raise reflects our strong capital allocation strategy – which has allowed us to effectively manage our cash, pay down debt and invest in the future of healthcare.

While we've been able to provide steady dividends since 1924 – a more than 90-year run – we've also increased our dividends for 47 straight years – showing our management’s commitment to shareholders. It's also a show of confidence in the future of the company while rewarding shareholders for sticking with us.

A Better Crowd to Socialize With: The Dividend Aristocrats

Abbott is a member of the S&P 500 Dividend Aristocrats Index, which recognizes companies who have raised their dividend payout for at least 25 years. During the last five years, the Dividend Aristocrats delivered 10.4 percent annualized total shareholder returns vs. the S&P 500's 10.0 percent. Abbott has performed even better during this time with 15.8 percent annualized total shareholder return.

Much of the outperformance of the Dividend Aristocrats has historically happened during economic downturns, making the Aristocrats a safer haven for capital when times get tough. The group often offers higher returns with less volatility than other shares, making them even more appealing during times of market unrest and global economic security.

Global players on the index have performed consistently over decades, and the dividend increases from these companies reflect both prudent management as well as leader confidence in future growth to justify the payouts to shareholders.

We're proud to be a member of this elite group. Our diverse businesses – in nutrition, diagnostics, medical device and established pharmaceuticals – provide balance across geographies helping us build a stronger company that delivers for our customers, shareholders, the communities we operate in and our employees.

To learn more about dividends, view our infographic.